Trial Profile
METRONOMIC CAPECITABINE IN ADVANCED HEPATOCARCINOMA: A PHASE II STUDY.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 May 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms Capemetro
- 29 Jul 2011 New trial record